Please use this identifier to cite or link to this item:
|Title:||Outcomes of Reduced Frequency Dosing of Ibrutinib in Chronic Lymphocytic Leukemia Patients Following Complete or Partial Remission: A Pilot Study|
|ISLHD Author:||Davis, Sarah|
|Citation:||J Hematol. 2020 Sep;9(3):55-61. doi: 10.14740/jh676. Epub 2020 Aug 14.|
|Journal Title:||J Hematol|
|Appears in Collections:||Research publications from current and former ISLHD staff.|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.